PHAXIAM Therapeutics S.A. (PHXM.PA)
EUR 1.73
(-0.57%)
EUR 1.73
(-0.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -24.42 Million | -31.98 Million | -57.14 Million | -52.04 Million | -43.5 Million | -39.27 Million |
| Net Income | -23.48 Million | -228 Thousand | -53.79 Million | -73.3 Million | -62.65 Million | -38.22 Million |
| Depreciation & Amortization | 1.22 Million | 2.9 Million | 5.37 Million | 4.99 Million | 4.21 Million | 797 Thousand |
| Deferred income taxes | -208 Thousand | 521 Thousand | 2000.00 | 3000.00 | -1000.00 | - |
| Stock-based compensation | 693 Thousand | 447 Thousand | 1.32 Million | 1.17 Million | 1.35 Million | - |
| Change in working capital | -857 Thousand | -8.09 Million | -7.15 Million | 10.8 Million | 13.73 Million | -406 Thousand |
| Other non-cash items | -2 Million | -11.99 Million | 15.66 Million | 8.13 Million | 2.61 Million | -7.25 Million |
| Investing Cash Flow | 171 Thousand | 38.12 Million | -345 Thousand | -1.47 Million | -19.83 Million | -15.03 Million |
| Investments in PPE | -217 Thousand | -85 Thousand | -298 Thousand | -1.14 Million | -20.13 Million | -14.22 Million |
| Acquisitions | 32 Thousand | 37.63 Million | - | 83 Thousand | - | - |
| Investment purchases | -4000.00 | -5000.00 | -192 Thousand | -421 Thousand | -119 Thousand | -812 Thousand |
| Sales/Maturities of investments | 360 Thousand | 586 Thousand | 145 Thousand | 4000.00 | 414 Thousand | - |
| Other Investing Activities | 388 Thousand | 1000.00 | -47 Thousand | -336 Thousand | 279 Thousand | - |
| Financing Cash Flow | -3.71 Million | -1.54 Million | 45.08 Million | 25.77 Million | 235 Thousand | -818 Thousand |
| Debt repayment | -3.77 Million | -1.54 Million | -12.15 Million | -27.07 Million | -738 Thousand | -818 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 34.63 Million | 130 Thousand | 47 Thousand | - |
| Other Financing Activities | 61 Thousand | -223 Thousand | 34.25 Million | 188 Thousand | 1.9 Million | - |
| Accounts receivables | 218 Thousand | -63 Thousand | -8000.00 | 33 Thousand | -7000.00 | 47 Thousand |
| Accounts payables | -1.21 Million | -9.22 Million | -6.47 Million | 6.91 Million | 5.99 Million | 8.57 Million |
| Inventory | - | - | - | 358 Thousand | 1.03 Million | -1.21 Million |
| Other working capital | -1.07 Million | 1.18 Million | -668 Thousand | 3.49 Million | 6.7 Million | -7.81 Million |
| Cash at beginning of period | 38.78 Million | 33.69 Million | 44.44 Million | 73.17 Million | 134.37 Million | 174.52 Million |
| Cash at end of period | 10.47 Million | 38.78 Million | 33.69 Million | 44.44 Million | 73.17 Million | 134.37 Million |
| Capital Expenditure | -217 Thousand | -85 Thousand | -298 Thousand | -1.14 Million | -20.13 Million | -14.22 Million |
| Effect of forex changes on cash | -342 Thousand | 495 Thousand | 1.65 Million | -981 Thousand | 1.91 Million | - |
| Net cash flow / Change in cash | -28.31 Million | 5.09 Million | -10.74 Million | -28.72 Million | -61.19 Million | -40.15 Million |
| Free Cash Flow | -24.64 Million | -32.07 Million | -57.44 Million | -53.18 Million | -63.63 Million | -53.49 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.31 Million | -5.31 Million | -23.48 Million | -5.59 Million | -5.69 Million | -12.2 Million |
| Depreciation & Amortization | 370 Thousand | - | 1.6 Million | 469 Thousand | - | 261 Thousand |
| Deferred income taxes | - | - | -208 Thousand | - | - | -208 Thousand |
| Stock-based compensation | - | - | 693 Thousand | 693 Thousand | -390 Thousand | 195 Thousand |
| Change in working capital | 59 Thousand | - | -2.06 Million | -2.39 Million | - | 321 Thousand |
| Other non-cash items | 5.31 Million | 5.31 Million | 4 Million | 4.9 Million | 6.08 Million | -239 Thousand |
| Investing Cash Flow | -458 Thousand | - | 171 Thousand | -19 Thousand | - | 190 Thousand |
| Investments in PPE | -437 Thousand | - | -217 Thousand | -164 Thousand | - | -53 Thousand |
| Acquisitions | 8000.00 | - | 32 Thousand | 22 Thousand | - | 10 Thousand |
| Investment purchases | - | - | -4000.00 | -4000.00 | - | - |
| Sales/Maturities of investments | 134 Thousand | - | 360 Thousand | 127 Thousand | - | 233 Thousand |
| Other Investing Activities | 1000.00 | - | 388 Thousand | - | - | 121.5 Thousand |
| Financing Cash Flow | -393 Thousand | - | -3.77 Million | -2.08 Million | - | -1.69 Million |
| Debt repayment | - | - | -2.72 Million | -1.44 Million | - | -1.28 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -393 Thousand | - | 61 Thousand | -638 Thousand | - | -809.5 Thousand |
| Accounts receivables | -152 Thousand | - | 218 Thousand | 142 Thousand | - | 76 Thousand |
| Accounts payables | -1.14 Million | - | -1.21 Million | -1.9 Million | - | 694 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.35 Million | - | -1.07 Million | -626 Thousand | - | -449 Thousand |
| Cash at beginning of period | 10.47 Million | - | 38.78 Million | 25.18 Million | - | 38.78 Million |
| Cash at end of period | 1.46 Million | - | 10.47 Million | 10.47 Million | - | 25.18 Million |
| Capital Expenditure | -437 Thousand | - | -217 Thousand | -164 Thousand | - | -53 Thousand |
| Effect of forex changes on cash | - | - | -342 Thousand | - | - | -138 Thousand |
| Net cash flow / Change in cash | -9.01 Million | - | -28.31 Million | -14.71 Million | - | -13.6 Million |
| Free Cash Flow | -8.77 Million | - | -24.58 Million | -12.71 Million | - | -11.87 Million |
OMAXAUTO
FMK
007690
PEDU
2378
PRAKIT